INMUNOGENETICA
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (16)
2020
-
The role of a functional variant of TYK2 in vasculitides and infections
Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 949-955
2013
2012
-
Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
PLoS ONE, Vol. 7, Núm. 11
-
Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
Journal of Hepatology, Vol. 56, Núm. 4, pp. 788-794
2011
-
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients
AIDS, Vol. 25, Núm. 6, pp. 761-766
2006
-
Incidence and distribution pattern of Rickettsia felis in peridomestic fleas from Andalusia, southeast Spain
Annals of the New York Academy of Sciences
2005
-
Ticks (Acarina: Ixodidae) as vectors and reservoirs of pathogen microorganims in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 2, pp. 94-102
2003
-
Diagnóstico del déficit de acil-CoA deshidrogenasa de cadena media mediante la reacción en cadena por la polimerasa en tiempo real
Quimica Clinica, Vol. 22, Núm. 1, pp. 9-12
2002
-
Presence of Rickettsia felis in the cat flea from southwestern Europe
Emerging Infectious Diseases, Vol. 8, Núm. 1, pp. 89-91
2001
-
Detection of nucleotide c985 A→G mutation of medium-chain acyl-CoA dehydrogenase gene by real-time PCR
Clinical Chemistry, Vol. 47, Núm. 5, pp. 958-959
1997
-
Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis
Journal of Hepatology, Vol. 26, Núm. 1, pp. 1-5
-
Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996 [2]
AIDS
-
Viraemia and p24 antigenaemia are independent risk factors for the emergence of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection
Antiviral Therapy, Vol. 2, Núm. 2, pp. 99-104
1996
-
A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals
Antiviral Therapy, Vol. 1, Núm. 2, pp. 105-112
-
Efecto del tratamiento con analogos de nucleosidos en sujetos con resistencia genotipica primaria a zidovudina [1]
Medicina Clinica
-
HIV-1 viraemia changes in patients with and without syncytium-inducing phenotype treated with nucleoside analogues: A case-control study
European Journal of Clinical Investigation, Vol. 26, Núm. 10, pp. 923-928